Generic placeholder image

Current Pharmaceutical Design


ISSN (Print): 1381-6128
ISSN (Online): 1873-4286


Advancement in Polymer and Lipid-based Nanotherapeutics for Cancer Drug Targeting

Author(s): Sarwar Beg, Md. A. Barkat and Farhan J. Ahmad

Volume 26, Issue 11, 2020

Page: [1127 - 1127] Pages: 1

DOI: 10.2174/138161282611200424113756

Next »
Ansari MA, Chung I-M, Rajakumar G, et al. Current nanoparticle approaches in nose to brain drug delivery and anticancer therapy - a review. Curr Pharm Des 2020; 26(11): 1128-37.
Ansari MA, Badrealam KF, Alam A, et al. Recent nano-based therapeutic intervention of bioactive sesquiterpenes: prospects in cancer therapeutics. Curr Pharm Des 2020; 26(11): 1138-44.
Barkat MA. Harshita, Rizwanullah Md, et al. Therapeutic nanoemulsion: concept to delivery. Curr Pharm Des 2020; 26(11): 1145-66.
Harshita Barkat Md. A, Das SS, Pottoo FH, Beg S, Rahman Z. Lipid-based nanosystem as intelligent carriers for versatile drug delivery applications. Curr Pharm Des 2020; 26(11): 1167-80.
Ahmad J. Ameeduzzafar, Ahmad MZ, Akhter H. Surface-engineered cancer nanomedicine: rational design and recent progress. Curr Pharm Des 2020; 26(11): 1181-90.
Harwansh RK, Bahadur S, Deshmukh R, Rahman MA. Exciting potential of nanoparticlized lipidic system for effective treatment of breast cancer and clinical updates: a translational prospective. Curr Pharm Des 2020; 26(11): 1191-205.
Rizwanullah Md, Alam M. Harshita, Mir SR, Rizvi MMA, Amin S. Polymer-lipid hybrid nanoparticles: a next-generation nanocarrier for targeted treatment of solid tumors. Curr Pharm Des 2020; 26(11): 1206-15.
Haider N, Fatima S, Taha M, et al. Nanomedicines in diagnosis and treatment of cancer: an update. Curr Pharm Des 2020; 26(11): 1216-31.

© 2024 Bentham Science Publishers | Privacy Policy